These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3413988)

  • 1. Antibody-mediated activation of Sindbis virus.
    Flynn DC; Olmsted RA; Mackenzie JM; Johnston RE
    Virology; 1988 Sep; 166(1):82-90. PubMed ID: 3413988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals.
    Olmsted RA; Meyer WJ; Johnston RE
    Virology; 1986 Jan; 148(2):245-54. PubMed ID: 2417415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and genetic characterization of Sindbis virus monoclonal antibody escape mutants which define a pathogenesis domain on glycoprotein E2.
    Pence DF; Davis NL; Johnston RE
    Virology; 1990 Mar; 175(1):41-9. PubMed ID: 2309450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons.
    Ubol S; Levine B; Lee SH; Greenspan NS; Griffin DE
    J Virol; 1995 Mar; 69(3):1990-3. PubMed ID: 7853547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conformational change in Sindbis virus glycoproteins E1 and E2 is detected at the plasma membrane as a consequence of early virus-cell interaction.
    Flynn DC; Meyer WJ; Mackenzie JM; Johnston RE
    J Virol; 1990 Aug; 64(8):3643-53. PubMed ID: 1695253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis.
    Chanas AC; Gould EA; Clegg JC; Varma MG
    J Gen Virol; 1982 Jan; 58 Pt 1():37-46. PubMed ID: 7142968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein.
    Schmaljohn AL; Kokubun KM; Cole GA
    Virology; 1983 Oct; 130(1):144-54. PubMed ID: 6195815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino-terminal residue of Sindbis virus glycoprotein E2 influences virus maturation, specific infectivity for BHK cells, and virulence in mice.
    Heidner HW; Johnston RE
    J Virol; 1994 Dec; 68(12):8064-70. PubMed ID: 7966596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro.
    Polo JM; Davis NL; Rice CM; Huang HV; Johnston RE
    J Virol; 1988 Jun; 62(6):2124-33. PubMed ID: 2835514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a biologically active antiviral antibody using a sindbis virus vector system.
    Liang XH; Jiang HH; Levine B
    Mol Immunol; 1997; 34(12-13):907-17. PubMed ID: 9464526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sindbis virus conformational changes induced by a neutralizing anti-E1 monoclonal antibody.
    Hernandez R; Paredes A; Brown DT
    J Virol; 2008 Jun; 82(12):5750-60. PubMed ID: 18417595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions in the putative cell receptor-binding domain of Sindbis virus strain MRE16 E2 glycoprotein reduce midgut infectivity in Aedes aegypti.
    Myles KM; Pierro DJ; Olson KE
    J Virol; 2003 Aug; 77(16):8872-81. PubMed ID: 12885905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sindbis virus neutralization.
    Westarp ME; Stanley J; Griffin DE
    Ann N Y Acad Sci; 1988; 540():566-7. PubMed ID: 3207286
    [No Abstract]   [Full Text] [Related]  

  • 14. Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals.
    Olmsted RA; Baric RS; Sawyer BA; Johnston RE
    Science; 1984 Jul; 225(4660):424-7. PubMed ID: 6204381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice.
    Stanley J; Cooper SJ; Griffin DE
    J Virol; 1986 Apr; 58(1):107-15. PubMed ID: 2419592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy.
    Smith TJ; Cheng RH; Olson NH; Peterson P; Chase E; Kuhn RJ; Baker TS
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10648-52. PubMed ID: 7479858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative forms of a strain-specific neutralizing antigenic site on the Sindbis virus E2 glycoprotein.
    Davis NL; Pence DF; Meyer WJ; Schmaljohn AL; Johnston RE
    Virology; 1987 Nov; 161(1):101-8. PubMed ID: 2445100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Site Glycoprotein Mutants Inhibit a Late Event in Sindbis Virus Assembly.
    Magliocca J; Vancini R; Hernandez R; Brown DT
    J Virol; 2016 Sep; 90(18):8372-80. PubMed ID: 27412592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiidiotypic antibodies as probes for the Sindbis virus receptor.
    Wang KS; Schmaljohn AL; Kuhn RJ; Strauss JH
    Virology; 1991 Apr; 181(2):694-702. PubMed ID: 2014644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.